AK-0706

N/A

Report date: 2025/09/10 17:24:34
NME

Base Information

Drug NameAK-0706
Drug Alias NameAK-0706
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTerminal nucleotidyltransferase 4A inhibitorsTerminal nucleotidyltransferase 4B inhibitors
TargetsTerminal nucleotidyltransferase 4ATerminal nucleotidyltransferase 4B
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Ark Biopharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Ark Biopharmaceutical Co Ltd
Inactive CompaniesXiamen Amoytop Biotech Co Ltd
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A